Low rates of HPV vaccination and cervical cancer screening: challenges and opportunities in the context of the COVID-19 pandemic

Smith, Debi L.; Perkins, Rebecca B.

Low rates of HPV vaccination and cervical cancer screening: challenges and opportunities in the context of the COVID-19 pandemic

Files

main.pdf (339.03 KB)

Authors

Smith, Debi L.

Perkins, Rebecca B.

Issue Date

2022-04-21

Type

Article

Language

en_US

Keywords

Cervical Cancer , Cervical Precancer , Screening , HPV , COVID-19 , SARS-CoV-2 , Pandemic , HPV Vaccination

Abstract

This invited commentary discusses the article by Richards et al. describing differences in rates of on-time HPV vaccination and cervical cancer screening in 2018 among enrollees in different insurance plans. The commentary focuses on the larger problem of low vaccination HPV rates and decreasing cervical cancer screening rates seen across all sectors. We outline challenges posed by the COVID-19 pandemic on HPV vaccination and cervical cancer screening, and discuss opportunities to improve cervical cancer prevention.

Citation

Smith, D. L., & Perkins, R. B. (2022). Low rates of HPV vaccination and cervical cancer screening: Challenges and opportunities in the context of the COVID-19 pandemic. Preventive medicine, 159, 107070. https://doi.org/10.1016/j.ypmed.2022.107070

Publisher

Preventive Medicine